Verastem | VSTM - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
AbbVie USD 3.63B 54M 2026-06
Alaunos Therapeutics USD 447K 138K 2026-03
AstraZeneca USD 5.8B 735M 2026-06
Curis USD 2.96M 1.62M 2026-03
Cytokinetics USD 104.4M 499K 2026-06
Gilead Sciences USD 1.52B 70M 2026-06
Incyte USD 351.73M 23.64M 2026-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Novartis USD 3.24B 101M 2026-06
Pfizer USD 3.41B 496M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
TG Therapeutics USD 62.32M 10.82M 2026-06
Verastem USD 22.3M 2.14M 2026-03